Class IITerminatedF-2400-2014
Supplement recall · September 3, 2014
PHEnFX (TM) recall
Why: The products contain DMAA, also known as 1,3-dimethylamylamine, methylhexamine or geranium extract, which is not permitted in dietary supplements.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
PHEnFX (TM), PHENO 550 mg, PHARMACEUTICAL GRADE, 90 CAPSULES, Manufactured for: Beta Labs, LTD, Newark, DE 19711, UPC 029882559802
- Lots / codes
Lot # 1205129, Exp 12/16
- Quantity
- 743 units
- Company
- Beta Labs, Memphis, TN
- Distribution
- nationwide and UK
- Initiated
- June 20, 2013 · Voluntary: Firm initiated
- Classified
- August 27, 2014
- Reported
- September 3, 2014
- Ended
- December 3, 2014
- How notified
- Press Release
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.